Friday, January 11, 2008

Chantex to help Quit Smoking

Chantex has been a big hit on the market for promoting to help people quit smoking.
Chantex also known as varenicline tartrate was approved on May 11, 2006 by the U.S FDA as the first new prescription medication for smoking cessation. The FDA has not approved of a similar product in the last ten years. Chantex was discovered and developed by Pfizer, Inc. headquartered in New York. It is the fourth new medicine by Pfizer to receive FDA approval in 2006.

Chantex is indeed a good news for the smokers or their loved ones who wish for them to quit. Pfizer scientists researched a specific molecule for smoking cessation that target the nicotine receptor. Chantex was approved based on six clinical trials involving more than 3,500 cigarette smokers. Chantex acts on the brain in areas affected by smoking in two ways: by providing some of the effects of nicotine to ease withdrawal symptoms and by blocking the effects of nicotine if smoking is resumed.

Chantex is not available over the counter as it is a prescription medicine. It is therefore only available if you have a doctor's prescription. Chantex comes in the form of a tablet, a 1mg table (blue) and a .5mg tablet (white). Your doctor will usually prescribe Chantex to you consecutively during a 12-week regimen. It is possible to have an additional 12-week regimen prescribed to you is to insure long-term success. The course of the treatment starts 7 days before you actually quit smoking. You would be given a 7-day treatment of Chantex, to be taken after meals with a full glass of water.

Unfortunately with any medication, there will be side effects. And some of the common ones are nausea, headache, vomiting, gas, insomnia, abnormal dreams and problems with taste.